Clinical Trial Update: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study from Johns Hopkins is evaluating psilocybin for depressive symptoms in people with mild cognitive impairment or early Alzheimer's disease and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Depressive Symptoms, Depression | EARLY_Phase 1 | Status: RECRUITING